CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net loss	$ (5,151)	$ (5,086)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	125	186
Recovery of doubtful accounts	0	(125)
Recovery of discounts, rebates, distributor fees and returns	(66)	(1,407)
Stock-based compensation	669	382
Forgiveness of PPP loan	0	(723)
Deferred income tax expense	(37)	(829)
Operating lease right-of-use asset	173	223
Gain on sale of assets	(1)	0
Changes in operating assets and liabilities:
Accounts receivable	62	1,971
Inventories	0	(100)
Prepaid expenses and other current assets	(306)	(460)
Deferred consideration, net of discount	190	160
Accounts payable	(864)	(157)
Accrued expenses and other current liabilities	127	679
Withholding tax payable	396	360
Operating lease liabilities	(173)	(222)
Deferred revenue	(1,296)	900
Net cash used in operating activities	(6,152)	(4,248)
Cash flows from investing activities:
Purchases of property and equipment	(269)	(137)
Deposits	11	38
Net cash used in investing activities	(258)	(99)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	2,868	7,554
Payments on PPP Loan	(120)	(467)
Proceeds from exercise of common stock options and purchase warrants	0	216
Principal payments on short-term debt	(774)	(30)
Proceeds on short-term debt	515	123
Net cash provided by financing activities	2,489	7,396
Effect of exchange rate on cash and cash equivalents	345	127
Net (decrease) increase in cash and cash equivalents	(3,576)	3,176
Cash and cash equivalents, beginning of year	7,396	4,220
Cash and cash equivalents, end of year	3,820	7,396
Supplemental disclosure of cash flow information:
Cash paid for interest	17	24
Cash paid for taxes	0	767
Non-cash operating and financing activities:
Insurance premiums financed	$ 515	$ 748